Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/08/2003WO2002092777A3 Dwf12 and mutants thereof
05/08/2003WO2002092624A3 G-protein coupled receptor
05/08/2003WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
05/08/2003WO2002090524A3 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
05/08/2003WO2002088321A3 Concentration and purification of analytes using electric fields
05/08/2003WO2002088171A3 Combinatorial libraries of monomer domains
05/08/2003WO2002088168A3 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
05/08/2003WO2002086132A3 Viral vector system to transduce or infect a target adipose tissue site
05/08/2003WO2002083076A3 Method for inhibiting atherosclerotic plaque formation
05/08/2003WO2002079433A3 Transgenic mice containing tmem3 beta-1,3-n-acetylglucosaminyltransferase gene disruptions
05/08/2003WO2002079409A3 Integrases for the insertion of heterologous nucleic acids into the plastid genome
05/08/2003WO2002072847A3 Process for production of polypeptides
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002064773A3 Method for high throughput screening of candidate compounds by high throughput direct synthesis of recombinant polypeptides
05/08/2003WO2002062131A8 Method of cloning transgenic mammalian animals using pseudonuclei
05/08/2003WO2002057497A3 High through-put cloning of protooncogenes
05/08/2003WO2002057226A3 68730 and 69112 protein kinase molecules and uses therefor
05/08/2003WO2002050118A3 Single-strand antibody with improved stability
05/08/2003WO2002048335A3 Metal resistant plants and use for phytoremediation
05/08/2003WO2002042467A3 Aspergillus fumigatus profilin
05/08/2003WO2002040679A3 Corynebacterium glutamicum promoters
05/08/2003WO2002034929A9 Expression vectors and uses thereof
05/08/2003WO2002026946A3 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
05/08/2003WO2002018552A8 Regulation of human aminotransferase-like enzyme
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001088133A3 Human semaphorin homologs and polynucleotides encoding the same
05/08/2003WO2001081378A3 G-protein coupled receptors
05/08/2003WO2001075454A3 Diagnosis and treatment of alzheimer's disease
05/08/2003WO2001057274A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
05/08/2003WO2000042183A3 Tumor marker zsig62
05/08/2003WO1999009179A3 Antigen constructs useful in the detection and differentiation of antibodies to hiv
05/08/2003WO1998055635A9 Methods of assaying receptor activity and constructs useful in such methods
05/08/2003US20030088890 Novel ecdysone receptors and methods for their use
05/08/2003US20030088888 Pre-treating a gypsophila plant with a gibberellin, obtaining a plant segment, co-cultivating said plant segment with an Agrobacterium vector comprising said nucleic acid of interest; and regenerating a transformed plant therefrom.
05/08/2003US20030088887 Transforming plants with genes that enhance disease resistance.
05/08/2003US20030088886 Chimeric genes, a first encoding a plant methionine synthase gene, a second encoding a plant cystathionine gamma-synthase gene, a third encoding feedback-insensitive aspartokinase
05/08/2003US20030088885 Enhanced resolution of tumor metastasis using a skin flap model
05/08/2003US20030088883 Having the reporter gene under operational control of the Colla1 promoter further comprising a regulatory element that regulates the expression of collagen.
05/08/2003US20030088881 Protection of proteins (e.g. fibrinogen) expressed in milk from transgenic animals by co-expression of a serine proteinase inhibitor (e.g. alpha 1-antitrypsin) in the milk of the transgenic animals.
05/08/2003US20030088384 Chemical substance classification apparatus, chemical substance classification method, and program
05/08/2003US20030088087 Purification of preferential nucleotide sequences; obtain nucleotide sequences, load onto column, elute, deprotect, load deprotected mixture onto column, elute and recover sequences
05/08/2003US20030088086 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infection
05/08/2003US20030088085 MPROT12 polynucleotides and methods thereof
05/08/2003US20030088084 Novel human zinc-binding proteins
05/08/2003US20030088083 Protein complexes for use as regulatory tools in plants
05/08/2003US20030088082 Nucleotide sequences coding polypeptide for use in veterinary medicine
05/08/2003US20030088081 High level expression of immunogenic proteins in the plastids of higher plants
05/08/2003US20030088074 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains
05/08/2003US20030088073 Scarecrow gene, promoter and uses thereof
05/08/2003US20030088061 Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing an allosteric regulatory site
05/08/2003US20030088060 Human ion channels
05/08/2003US20030088058 Isopenicillin n synthetase and deacetoxycephalosporin c synthetase enzymes and methods
05/08/2003US20030087872 Fucosidase 32616 is differentially expressed in tumor and/or angiogenic tissue samples as compared to normal tissue samples
05/08/2003US20030087871 Antisense modulation of caspase 9 expression
05/08/2003US20030087866 Suppression of malignancy utilizing ribonucleotide reductase R1
05/08/2003US20030087861 Administering mixture of antibody and drug; cancer sensitivity
05/08/2003US20030087860 Methods for sexing non-human mammals
05/08/2003US20030087859 Therapy for vision defects, central nervous system disorders; retinal pigment epithelium; genetic engineering
05/08/2003US20030087857 Antisense modulation of insulin-like growth factor binding protein 5 expression
05/08/2003US20030087856 Antisense modulation of IL-1 receptor-associated kinase-4 expression
05/08/2003US20030087855 Antisense modulation of protein kinase R expression
05/08/2003US20030087854 Hybrid nucleic acids; prevent, controlling gene expression
05/08/2003US20030087853 Antisense modulation of apolipoprotein B expression
05/08/2003US20030087851 Pharmaceutical composition for treating or preventing influenza, and novel oligonucleotide
05/08/2003US20030087849 Antisense modulation of HKR1 expression
05/08/2003US20030087848 Antihistamines, antiallergens
05/08/2003US20030087847 Method and reagent for the inhibition of checkpoint kinase-1 (Chk1) enzyme
05/08/2003US20030087845 Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
05/08/2003US20030087818 Compositions and methods for the therapy and diagnosis of colon cancer
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087815 Novel polypeptides and nucleic acids encoding same
05/08/2003US20030087810 Controlling gene expression in cells; anticancer agents; drug delivery
05/08/2003US20030087807 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
05/08/2003US20030087763 Method to promote growth of a plant
05/08/2003US20030087762 Auxinic analogues of indole-3-acetic acid
05/08/2003US20030087440 Ketogulonigenium endogenous plasmids
05/08/2003US20030087439 Transfer of nucleotide sequences into plant cells; obtain plasmid, incubate with nucleotide sequences, insert nuclotide sequences into plasmid, obtain plant cell, incubate with plasmid, recover transformed cells
05/08/2003US20030087438 E1-revertant-free adenoviral composition
05/08/2003US20030087437 Amplification of efficiency of gene tranfer into cells; obtain cells, icubate with genetically engineered retrovirus, transduce cells, recover transformed cells
05/08/2003US20030087436 Process for the production of biologically active polymeric nanoparticle-nucleic acid conjugates
05/08/2003US20030087435 Catalytic antibodies raised against sarin; an organophosphorous anticholinesterase, and an antigen and process for the preparation thereof
05/08/2003US20030087434 Process for selective expression of nucleic acid products
05/08/2003US20030087432 Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture, methods for assaying the effect of substances on lineage-specific cell production, and cell compositions produced by these cultures
05/08/2003US20030087431 Embryonic cells for use as tools in in vitro fertilization
05/08/2003US20030087420 Transgenic animals and cells expressing proteins necessary for susceptibility to HIV infection
05/08/2003US20030087419 Transgenic cell for use in the packaging and controlling expression of viral or heterologous nucleotide sequences >>> TITLE
05/08/2003US20030087418 Detection; cell differentiation; sensitivity to cell microbiocides, parasites
05/08/2003US20030087417 Newcastle disease virus infectious clones, vaccines and diagnostic assays
05/08/2003US20030087415 Extracellular expression of pectate lyase using Bacillus or Escherichia coli
05/08/2003US20030087414 Mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087406 Synthases
05/08/2003US20030087405 Products encoded by a methymycin/pikromycin biosynthetic gene cluster
05/08/2003US20030087404 Generation of pantothenic acid and/or a salt; obtain microorganisms, ferment and recover pantothenic acid or salt
05/08/2003US20030087403 Biological method for the production of adipic acid and intermediates
05/08/2003US20030087402 Process for the preparation of (S) - or (R) -3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid
05/08/2003US20030087400 Generation of lysine; obtain bacteria, incubate with nutrient broth, ferment, accumulate and recover lysine
05/08/2003US20030087398 Polymerase chain reaction
05/08/2003US20030087397 Multiplex real-time PCR
1 ... 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 ... 4023